Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1380078-95-4
2. Plazomicin Sulfate [usan]
3. Plazomicin Sulfate (usan)
4. (2s)-4-amino-n-[(1r,2s,3s,4r,5s)-5-amino-4-[[(2s,3r)-3-amino-6-[(2-hydroxyethylamino)methyl]-3,4-dihydro-2h-pyran-2-yl]oxy]-2-[(2r,3r,4r,5r)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide;sulfuric Acid
5. Plazomicin Hemipentasulfate
6. (s)-4-amino-n-((1r,2s,3s,4r,5s)-5-amino-4-(((2s,3r)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2h-pyran-2-yl)oxy)-2-(((2r,3r,4r,5r)-3,5-dihydroxy-5-methyl-4-(methylamino)tetrahydro-2h-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide Sulfate(1:x)
7. A78l6mt746
8. Unii-a78l6mt746
9. Zemdri (tn)
10. Chembl2364623
11. Dtxsid60160452
12. D10655
13. Q27273718
14. (2s)-4-amino-n-((1r,2s,3s,4r,5s)-5-amino-4-((2-amino-2,3,4,6-tetradeoxy-6-((2-hydroxyethyl)amino)-alpha-d-glycero-hex-4-enopyranosyl)oxy)-2-((3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide Sulfate
15. D-streptamine, O-2-amino-2,3,4,6-tetradeoxy-6-((2-hydroxyethyl)amino)-alpha-d-glycero-hex-4-enopyranosyl-(1->4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl-(1->6))-n(sup 1)-((2s)-4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, Sulfate (1:?)
Molecular Weight | 690.8 g/mol |
---|---|
Molecular Formula | C25H50N6O14S |
Hydrogen Bond Donor Count | 13 |
Hydrogen Bond Acceptor Count | 19 |
Rotatable Bond Count | 13 |
Exact Mass | 690.31057146 g/mol |
Monoisotopic Mass | 690.31057146 g/mol |
Topological Polar Surface Area | 352 Ų |
Heavy Atom Count | 46 |
Formal Charge | 0 |
Complexity | 954 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 12 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product ...
Market Place
Reply
27 Nov 2024
Reply
18 Sep 2023
Reply
21 Aug 2023
Reply
10 Jan 2023
Reply
24 Dec 2022
Reply
04 Nov 2022
Reply
20 Aug 2022
Reply
27 Apr 2022
Reply
21 Apr 2022
Reply
22 Mar 2022
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Plazomicin Sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Plazomicin Sulfate, including repackagers and relabelers. The FDA regulates Plazomicin Sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Plazomicin Sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Plazomicin Sulfate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Plazomicin Sulfate supplier is an individual or a company that provides Plazomicin Sulfate active pharmaceutical ingredient (API) or Plazomicin Sulfate finished formulations upon request. The Plazomicin Sulfate suppliers may include Plazomicin Sulfate API manufacturers, exporters, distributors and traders.
click here to find a list of Plazomicin Sulfate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Plazomicin Sulfate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Plazomicin Sulfate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Plazomicin Sulfate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Plazomicin Sulfate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Plazomicin Sulfate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Plazomicin Sulfate suppliers with NDC on PharmaCompass.
Plazomicin Sulfate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Plazomicin Sulfate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Plazomicin Sulfate GMP manufacturer or Plazomicin Sulfate GMP API supplier for your needs.
A Plazomicin Sulfate CoA (Certificate of Analysis) is a formal document that attests to Plazomicin Sulfate's compliance with Plazomicin Sulfate specifications and serves as a tool for batch-level quality control.
Plazomicin Sulfate CoA mostly includes findings from lab analyses of a specific batch. For each Plazomicin Sulfate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Plazomicin Sulfate may be tested according to a variety of international standards, such as European Pharmacopoeia (Plazomicin Sulfate EP), Plazomicin Sulfate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Plazomicin Sulfate USP).
LOOKING FOR A SUPPLIER?